Holocene Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$879K Buy
+4,793
New +$883K ﹤0.01% 690
2025
Q4
Sell
-5,979
Closed -$838K 753
2025
Q3
$838K Buy
+5,979
New +$808K ﹤0.01% 639
2023
Q3
Sell
-3,791
Closed -$1.08M 722
2023
Q2
$1.08M Sell
3,791
-190,314
-98% -$56.7M ﹤0.01% 627
2023
Q1
$54M Buy
+194,105
New +$53.7M 0.27% 125
2021
Q3
Sell
-1,370
Closed -$474K 812
2021
Q2
$474K Buy
+1,370
New +$415K ﹤0.01% 750
2020
Q2
Sell
-227,469
Closed -$68.4M 618
2020
Q1
$72M Sell
227,469
-22,473
-9% -$6.82M 0.77% 33
2019
Q4
$74.2M Buy
+249,942
New +$69.3M 0.66% 50
2018
Q2
Sell
-926
Closed -$254K 578
2018
Q1
$254K Buy
+926
New +$287K 0.01% 432

Other funds holding BIIB

Holocene Advisors's BIIB Position: Q1 2026 in Review

Holocene Advisors opened a new position in Biogen (BIIB) in Q1 2026: 4,793 shares worth $879K. The stake represents ﹤0.01% of the portfolio and ranks #690 among its holdings. This is a return to the name: Holocene Advisors previously reported a position in BIIB as recently as Q3 2025.

Holocene Advisors first reported a position in BIIB in Q1 2018 and has held it in 8 quarters since. The position peaked at $74.2M in Q4 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Holocene Advisors held 4,793 shares of Biogen worth $879K as of Q1 2026.
  • Biogen was a new Holocene Advisors position in Q1 2026.
  • Biogen made up ﹤0.01% of Holocene Advisors's portfolio in Q1 2026, its #690 holding.
  • Holocene Advisors first reported a position in Biogen in Q1 2018 and has held it in 8 quarters since.
  • Holocene Advisors's Biogen position peaked at $74.2M in Q4 2019.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.